AMP webinar with John Shakow

Massive Changes in the Pharmaceutical Industry are a now a reality

On-Demand Webinar presented by

John Shakow,
Partner, King & Spalding

John’s practice focuses on complex regulatory, commercial and litigation issues related to all aspects of drug pricing and price reporting. He counsels a diverse group of pharmaceutical and biotechnology manufacturer clients on all pricing-related rights and obligations under the Medicaid, Medicare, Federal Supply Schedule, 340B and TRICARE programs.

The CMS finished work on the “AMP Rule” and is expected to formally publish it in the Federal Register shortly. The AMP rule will transform government compliance requirements in the Pharmaceutical industry and significantly impact your business.

What does the AMP rule mean to you?
Are you prepared for the changes?
How much time do you have to comply?

Join us for this informative on-demand webinar titled 'The AMP Rule is Final – What is the impact?' featuring John Shakow who shares his insights on the final AMP rule.

View the on-demand webinar!

Lead Source:

Sub Industry:

utm_last_campaign:

utm_last_content:

utm_last_medium:

utm_last_source:

utm_last_term:

Demandbase SID:

Dbase-Company Name:

Dbase-Industry:

Dbase-Sub Industry:

Dbase-Employee Range:

Dbase-Revenue Range:

Dbase-Street Address:

Dbase-City:

Dbase-State:

Dbase-Zip:

Dbase-Phone:

Dbase-Country Name:

Dbase-Primary SIC:

Watch List Account Type:

Watch List Account Status:

Watch List Campaign Code:

Watch List Account Owner:

Dbase-Data Source:

John Shakow,Partner, King & Spalding

John Shakow,
Partner, King & Spalding